Open AccessEnzalutamide Versus Abiraterone as a First-Line Endocrine Therapy for Castration-Resistant Prostate Cancer: Protocol for a Multicenter Randomized Phase 3 Trial
Author(s) -
Isao Hara,
Shimpei Yamashita,
Satoshi Nishizawa,
Kazuro Kikkawa,
Toshio Shimokawa,
Yasuo Kohjimoto
Publication year - 2018
Publication title -
jmir research protocols
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.378
H-Index - 9
ISSN - 1929-0748
DOI - 10.2196/11191
Subject(s) - enzalutamide , prostate cancer , abiraterone , medicine , abiraterone acetate , protocol (science) , oncology , randomized controlled trial , androgen deprivation therapy , cancer , alternative medicine , androgen receptor , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom